Theorem Clinical Research

Articles Published in 2008

Phase Forward Acquires IRT Provider Clarix

Monday, September 8, 2008 01:00 PM

Waltham, Mass.-based eClinical technology company Phase Forward has acquired Clarix, a privately held provider of Web-integrated interactive response technology (IRT) based in Radnor, Pa., for $40 million in cash.

More... »

Quest Diagnostics

U.S. Disease Foundation Investment in Biopharmaceutical Industry Up 20% in 2008

Friday, September 5, 2008 11:00 AM

U.S. disease foundations will invest about $90 million this year in biopharmaceutical companies to fund discovery and development of new drugs and therapies for their corresponding diseases, according to CenterWatch estimates.

More... »

MDS Pharma Profits Sink in 3rd Quarter

Thursday, September 4, 2008 01:33 PM

Canadian life science company MDS, the parent company of King of Prussia, Pa.-based CRO MDS Pharma Services, reduced its fiscal 2008 revenue and profit outlook after reporting lower than expected third-quarter results in its contract research division. The company now expects fiscal 2008 revenue to be in the range of $1.23 billion to $1.25 billion, down from its previous forecast of $1.25 billion to $1.29 billion.

More... »

CenterWatch Monthly August 2008 Issue

Wednesday, September 3, 2008 04:18 PM

Central and Eastern Europe Triples Global Trial Participation

More... »

Report Questions Safety, Ethics of Clinical Trials in India

Tuesday, September 2, 2008 09:00 AM

India’s booming clinical trials business is under scrutiny, following a story in a UK newspaper that set off a flurry of media and regulatory attention.

More... »

Aptuit Founding CEO Resigns

Thursday, August 28, 2008 01:00 PM

Greenwich, Conn.-based Aptuit, a contract research organization (CRO), named Timothy (Tim) C. Tyson, a pharmaceutical industry veteran, as executive chairman and acting CEO, replacing Michael A. Griffith, the company’s founder and CEO since 2005. The company said Griffith resigned to pursue other opportunities.

More... »

RadPharm Appoints new CIO

Wednesday, August 27, 2008 01:00 PM

RadPharm appointed Steven F. Owens to the newly created position of chief information officer. In this role, Owens will provide leadership to IT and development projects that enhance RadPharm’s technical capabilities and business processes. Before joining RadPharm, Owens was senior director of R&D at the Center for Imaging and Innovation.

More... »

Oncology Accounts for Most Registered Clinical Trials, Rheumatology Sees Growth

Tuesday, August 26, 2008 01:00 PM

Oncology accounted for the most registered clinical trials as of Nov. 1, 2007, according to a recent review of U.S. trials data on The analysis, conducted by Nature Reviews, examined two years of data for industry-sponsored phase II through phase IV trials, including trials that were first registered between October 2005 and September 2007. Oncology, central nervous system disorders, cardiology, infectious diseases, endocrinology and respiratory diseases accounted for almost two-thirds of all protocols and more than two-thirds of all sites. Rheumatology saw the highest relative growth in the number of trials, making rheumatoid arthritis the third most common disease for clinical trials.

More... »

Merck Report Could Alter Clinical Trials, Marketing

Monday, August 25, 2008 01:00 PM

A new report criticizing the use of seeding trials to drive pharmaceutical marketing efforts and jump-start sales could have far-reaching implications for pharmaceutical companies, research sites and clinical trials in general.

More... »

CenterWatch Commentary: Experimental Drug Access Wars Continue

Friday, August 22, 2008 09:00 AM

A U.S. District judge Wednesday ordered PTC Therapeutics to supply its experimental drug to 16-year-old Jacob Gunvalson, who has Duchenne muscular dystrophy, a terminal disease for which there is no known cure.

More... »



March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs